Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText.
Kick-your-searchterm to multiple Engines kick-your-query now !>
A dictionary by aggregated review articles of nephrology, medicine and the life sciences
Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

suck abstract from ncbi


10.1159/000515344

http://scihub22266oqcxt.onion/10.1159/000515344
suck pdf from google scholar
33756475!8089442!33756475
unlimited free pdf from europmc33756475    free
PDF from PMC    free
html from PMC    free

suck abstract from ncbi


Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534

Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534

Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
pmid33756475      Chemotherapy 2021 ; 66 (1-2): 24-32
Nephropedia Template TP

gab.com Text

Twit Text FOAVip

Twit Text #

English Wikipedia


  • Targeting Microbiome: An Alternative Strategy for Fighting SARS-CoV-2 Infection #MMPMID33756475
  • Spagnolello O; Pinacchio C; Santinelli L; Vassalini P; Innocenti GP; De Girolamo G; Fabris S; Giovanetti M; Angeletti S; Russo A; Mastroianni CM; Ciccozzi M; Ceccarelli G; d'Ettorre G
  • Chemotherapy 2021[]; 66 (1-2): 24-32 PMID33756475show ga
  • Respiratory and gastrointestinal symptoms are the predominant clinical manifestations of the coronavirus disease 2019 (COVID-19). Infecting intestinal epithelial cells, the severe acute respiratory syndrome coronavirus-2 may impact on host's microbiota and gut inflammation. It is well established that an imbalanced intestinal microbiome can affect pulmonary function, modulating the host immune response ("gut-lung axis"). While effective vaccines and targeted drugs are being tested, alternative pathophysiology-based options to prevent and treat COVID-19 infection must be considered on top of the limited evidence-based therapy currently available. Addressing intestinal dysbiosis with a probiotic supplement may, therefore, be a sensible option to be evaluated, in addition to current best available medical treatments. Herein, we summed up pathophysiologic assumptions and current evidence regarding bacteriotherapy administration in preventing and treating COVID-19 pneumonia.
  • |*COVID-19/immunology/physiopathology/prevention & control[MESH]
  • |*Dysbiosis/therapy/virology[MESH]
  • |Dietary Supplements[MESH]
  • |Gastrointestinal Microbiome/*immunology[MESH]
  • |Humans[MESH]
  • |Probiotics/*pharmacology[MESH]


  • DeepDyve
  • Pubget Overpricing
  • suck abstract from ncbi

    Linkout box